Search Results

Uterine Artery Embolization of Uterine Fibroids

By Michael L. Censullo, MD; Polina N. Kyriakides, MD; Lucho L. Rossman, MD; and Alan M. Cohen, MD

IAC Vein Center Accreditation

How we got here, where we are now, and goals for the future.

By Lowell S. Kabnick, MD, RPhS, FACS, FACPh, and Alan M. Dietzek, MD, RPVI, FACS

Revolutionizing Pulmonary Embolism Care: The AI Advantage

The evolving role of artificial intelligence in pulmonary embolism diagnosis and management, current challenges, and future directions.

By Zehra Dhanani, MD; Nidhi Shah, MD; Maruti Kumaran, MD; Gary Cohen, MD; and Parth Rali, MD

IMA Embolization During Index EVAR: Is It Worthwhile?

Indications, currently available data, and considerations for future studies.

By Harry Hok Yee Yu, MBBS, FRCS(Edin), and Kevin Mani, MD, PhD

Type II Endoleaks: Will They Ever Be Conquered?

A review of type II endoleak natural history, frequency in procedures, imaging modalities, and current treatment options.

By Sharif H. Ellozy, MD

Endovascular Oncology

By Peter H. Lin, MD, Michael J. Wallace, MD

Combination Locoregional and Immunotherapy in Practice

Beau B. Toskich, MD, leads Rony Avritscher, MD; Kirema Garcia-Reyes, MD; and Nora Tabori, MD, through a series of questions about their approaches to combining local therapy with immunotherapy, how/if recent data have impacted their decision-making, preferences on type of immunotherapy, emerging applications, and more.

Pearls and Pitfalls: Radial First for Neurointervention

Tips for navigating the learning curve to gain proficiency in transradial neurointervention.

By Stephanie H. Chen, MD, and Eric C. Peterson, MD

Utility of Procedural Checklists in SFA Interventions

The use of checklists can improve outcomes and ensure the safety and efficiency of endovascular SFA procedures.

By Michael S. Hong, MD, and David L. Dawson, MD

Blunt Thoracic Aortic Injury: Current Issues and Endovascular Treatment Paradigms

The 2011 SVS TEVAR for BTAI clinical guidelines raised a number of unanswered questions. How have they been resolved since then?

By Joshua D. Adams, MD, and John A. Kern, MD

BCLC Staging and Treatment Algorithm: Does It Cover All?

The Barcelona Clinic Liver Cancer staging system is a commonly used algorithm for the management of HCC; however, there are key deviations in contemporary practice.

By Altan Ahmed, MD, MSc; Richard Kim, MD; Daniel A. Anaya, MD, MSHCT, FACS; and Bela Kis, MD, PhD, FSIR

Why Extravascular Closure?

The Baptist Memorial Hospital Experience with the Mynx¨ Vascular Closure Device.

By David Wolford, MD, FACC

Much Supply Confers Great Demand: Renal Denervation for Resistant Hypertension

A discussion of a challenging case of renal artery denervation for resistant hypertension.

By Brian Fulton, MD; Taisei Kobayashi, MD; and Jay Giri, MD, MPH

The Future of Artificial Intelligence in Interventional Oncology

Potential applications of AI within IO include patient diagnosis, response prediction, and intraprocedural guidance, dependent upon standardized and responsible implementation.

By Helen Zhang, BS; Shreyas Kulkarni, BS; Zhicheng Jiao, PhD; and Harrison X. Bai, MD, MS

Acute Ischemic Stroke Due to Tandem Occlusion

Planning an endovascular approach for an uncommon scenario.

By Alex B. Chebl, MD, FSVIN

Stroke Care Trends During the COVID-19 Pandemic

Three neurointerventionalists share their experiences treating stroke amidst the pandemic, thoughts on why some institutions are seeing a lower incidence of stroke, and a look at the Society for NeuroInterventional Surgery’s public awareness initiative.

With Dorothea Altschul, MD, FAHA; Richard P. Klucznik, MD; and James Milburn, MD, FACR